[Balneotherapeutics of non-alcoholic fatty liver disease with the use of the Essentuki-type drinking mineral waters].
The objective of the present work was to estimate the effectiveness of combined spa-and-resort treatment with the use of the Essentuki-type drinking mineral waters for the patients presenting with non-alcoholic fatty liver disease. A total of 40 patients presening with non-alcoholic fatty liver disease (NOFLD) were available for the examination. The study has demonstrated positive dynamics of clinical symptoms and results of liver functional tests, characteristics of intrahepatic dynamics, lipid metabolism, antioxidant hemostais, and the hormonal status of the patients with non-alcoholic fatty liver disease. The intake of the Essentuki-type drinking mineral waters promoted normalization of adiponectin and leptin levels in conjunction with the reduction in the degree of insulin resistance, i.e., the key pathogenetic factors responsible for hepatic steatosis and non-alcoholic steatohepatitis. It is concluded that the Essentuki-type drinking mineral waters may be recommended for the inclusion in the combined treatment and prevention of the progression of non-alcoholic fatty liver disease.
T E
TE
Fedorova
N V
NV
Efimenko
A S
AS
Kaĭsinova
D000328:Adult; D000975:Antioxidants / Q000378:metabolism; D001452:Balneology / Q000379:methods*; D005234:Fatty Liver / Q000097:blood / Q000628:therapy*; D005260:Female; D006487:Hemostasis / Q000187:drug effects; D006801:Humans; D007333:Insulin Resistance; D050356:Lipid Metabolism / Q000187:drug effects; D008297:Male; D008900:Mineral Waters / Q000008:administration & dosage*; D065626:Non-alcoholic Fatty Liver Disease
D000975:Antioxidants; D008900:Mineral Waters